TRIM65 promotes tumor cell proliferation by ubiquitinating and degrading the tumor suppressor gene BTG3, which alleviates G2/M cell cycle arrest, thereby advancing RCC through metabolic changes [126]. Here, TRIM65 is linked to renal cell carcinoma.